Radiotherapy (RT) is the cornerstone component of the current successful treatment of Hodgkin lymphoma
(HL). Although RT has been used alone to cure in most patients in decades, combined modality
regimes are preferred in most HL patients currently, besides early-stage lymphocyte predominance HL
and for selected patients with classical HL who have contraindications to chemotherapy. Although classic
RT fields, doses, and techniques have fundamentally changed over the years, the heart is still an organ
at risk, and patients with radiation-induced cardiovascular complications are increased in the long
term. In this paper, we aimed to review literature about radiation-induced cardiotoxicity in lymphoma
patients treated with mediastinal RT.
Keywords: Cardiotoxicity; Hodgkin Lymphoma (HL); radiotherapy
